Immunoglobulin GM ({gamma} marker) allotypes expressed on IgG1 as potential genetic markers of response to immune checkpoint blockade therapy
The results of a recent comprehensive investigation—confirmed in multiple cohorts—show that patients with hepatocellular carcinoma, who favorably responded to anti-programmed cell death protein 1 (PD-1) therapy, were enriched in IgG1-produ…